2290 — Lung Fung group Income Statement
0.000.00%
Last trade - 00:00- HK$1.87bn
- HK$2.80bn
- HK$3.28bn
Annual income statement for Lung Fung group, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1,094 | 2,021 | 2,460 | 3,277 |
| Cost of Revenue | ||||
| Gross Profit | 272 | 593 | 778 | 1,015 |
| Selling / General / Administrative Expenses | ||||
| Operating Interest Expense / Income | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 1,087 | 1,787 | 2,191 | 2,909 |
| Operating Profit | 7.3 | 234 | 270 | 369 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -25.2 | 181 | 218 | 327 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -27.1 | 145 | 170 | 269 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -27.1 | 145 | 170 | 269 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -27.1 | 145 | 170 | 269 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.054 | 0.289 | 0.341 | 0.563 |